1 Result(s)

Article

Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience

Rituximab is a human/murine, chimeric anti-CD20 monoclonal antibody with established efficacy, and a favorable and well-defined safety profile in patients with various CD20-expressing lymphoid malignancies, in...

Gilles Salles, Martin Barrett, Robin Foà, Joerg Maurer… in Advances in Therapy (2017)